Riluzole is an anti-glutamate agent which has been approved in various countries for the treatment of neurological disorders like amyotrophic lateral sclerosis (ALS) and also for Parkinson's disease and Alzheimer's disease. It has been found to have neuroprotective as well as neuromodulatory actions. In the treatment of ALS, it is used to slow the progression of the disease and delay the decrease in the function of motor neurons.
Riluzole is used to treat Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's disease, which is a fatal progressive neurodegenerative disease. It has been found to slow the progression of the disease and decrease the decrease in function of motor neurons. Riluzole also has potential to be used in the treatment of Parkinson's disease, Alzheimer's disease, and Huntington disease.
| Brand Name | Riluzole |
|---|---|
| Type | |
| Weight | |
| Generic | Riluzole |
| Manufacturer | |
| Available in | English বাংলা |
Riluzole blocks the action of glutamate, a neurotransmitter which can lead to neuronal damage when present in excess, by inhibiting its action and binding to glutamate receptors in the brain. By blocking the action of glutamate, riluzole helps to protect the neurons from further damage, which could slow the progression of ALS and delay the decrease in motor neuron function. Riluzole has also been found to modulate the activity of gamma-aminobutyric acid (GABA), a neurotransmitter involved in motor neuron activity.
Riluzole usually begins to take effect several weeks after the first dose is taken, but its effects increase over time. Therefore, it may take a few months for the full benefits of the drug to be seen.
Riluzole is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations achieved approximately 2 hours after oral administration.
Riluzole is metabolized in the liver and is primarily eliminated in the urine, with small amounts eliminated in the feces.
The usual recommended dose of Riluzole is 50mg twice a day, taken orally with a meal. For patients with kidney impairment, the dose should be adjusted according to the severity of kidney impairment, and in the case of liver impairment, the dose should be decreased to 25 mg twice a day.
Riluzole should be taken orally with a meal. Tablets should be swallowed whole with liquid. The drug should not be crushed or chewed.
Common side effects of Riluzole include dizziness, headaches, nausea, and fatigue. Rare but serious side effects include liver failure, severe skin reactions, and increased risk of suicidal thoughts and behaviors.
Riluzole is typically well-tolerated but can be toxic at varyingly high doses. It is therefore important to follow the instructions of your health care provider when taking the drug, and to ask any questions about the side effects if they occur.
Riluzole should be used with caution in patients with kidney or liver impairment, as well as in those taking other medication. It should not be used in pregnant or nursing women, and it is not recommended for children.
Riluzole may interact with certain other drugs, including antidepressants, antipsychotic medications, anti-seizure medications, and other drugs used to treat ALS. Therefore, it is important to tell your doctor about all the medications you are taking before taking Riluzole .
Riluzole can interact with certain diseases such as liver disorders, kidney disorders, and breathing problems. It is therefore important to let your doctor know any pre-existing diseases before taking Riluzole .
Riluzole may interact with certain drugs, including antiseizure medication, certain antidepressants, and drugs used for the treatment of amyotrophic lateral sclerosis (ALS). Therefore, it is important to tell your doctor about all the medications you are taking before taking Riluzole .
Riluzole should not be taken with foods high in tyramine (such as aged cheeses, cured meats, and fermented soy products), as this may cause an increase in side effects such as headache and nausea.
Riluzole is not recommended for use in pregnant women, as it has not been adequately studied in pregnant women and may cause harm to the fetus. If you are pregnant, or become pregnant while taking Riluzole , you should talk to your doctor about the potential risks.
Riluzole is not recommended for use in breastfeeding women, as it has not been adequately studied in breastfeeding women and may cause harm to the nursing baby. If you are breastfeeding, or plan to breastfeed while taking Riluzole , you should talk to your doctor about the potential risks.
In case of an acute overdose, seek medical help immediately. Symptoms of an acute overdose can include nausea, dizziness, hypothermia, and seizures.
Riluzole should not be used in patients with known hypersensitivity to the drug or any of its components.
Riluzole should be taken orally with a meal, as directed by your doctor. Tablets should be swallowed whole with liquid. The drug should not be crushed or chewed.
Riluzole should be stored at room temperature, away from direct sunlight, and kept away from pets and children.
The volume of distribution of Riluzole is 35.7L. This volume indicates that the drug is widely distributed throughout the body.
The half-life of Riluzole is 1.7-2 hours. This indicates that it takes approximately 1.7-2 hours for the drug to be eliminated from the body.
The clearance of Riluzole is 18.7L/hr. This means that the drug is eliminated from the body at a rate of 18.7L per hour.
See in details version Riluzole also Riluzole in bangla